| Execution period | 4 years from vesting |
|---|
BSE filing, NSE: GALAXYSURF. Summary written from the filing by ALFA Finder's alert engine.
Galaxy Surfactants Ltd: key numbers
- Share price
- ₹2,169.70
- Market cap
- ₹7,695 Cr
- Revenue (annual)
- ₹5,248 Cr
- Net profit (annual)
- ₹267.4 Cr
- P/E (TTM)
- 21.8×Sector 34.1×
- Promoter holding
- 70.90%+0.00% QoQ
- FII holding
- 3.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Galaxy Surfactants Ltd
All →Galaxy Surfactants Board Meeting Date
Galaxy Surfactants Ltd has called a board meeting on November 4, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026 and an interim dividend for FY27, if any. The filing is an advance notice with no figures disclosed.
Galaxy Surfactants Annual General Meeting
Galaxy Surfactants Ltd has issued a Postal Ballot notice for shareholder approval of two key resolutions. These include appointing Mr. Uday K. Kamat as Director and approving a related-party transaction.
- Value
- ₹1.54 Cr
- Execution
- 3 years
Galaxy Surfactants Annual General Meeting
Galaxy Surfactants filed a postal ballot notice seeking approval for a subsidiary director appointment and a new Non-Executive Director. E-voting runs October 19 to November 17, 2026.
Galaxy Surfactants Other Announcement
Galaxy Surfactants Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31 disclosure requirements.
Galaxy Surfactants Management Change
Galaxy Surfactants Ltd has appointed Uday K. Kamat as an Additional Non-Executive, Non-Independent Director, effective October 05, 2026, subject to shareholder approval.
Galaxy Surfactants Partnership
Galaxy Surfactants Ltd. signed a Partnership Growth Charter with Unilever to accelerate next-generation surfactant technologies. The collaboration focuses on bio-based alternatives and lower-carbon technologies for future growth.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.